Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes

The effects of twice-daily GLP-1 analogue injections added on continuous subcutaneous insulin infusion (CSII) in patients with poorly controlled type 2 diabetes (T2DM) were unknown. After optimization of blood glucose in the first 3 days by CSII during hospitalization, patients with poorly controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chia-Hung, Hsieh, Sheng-Hwu, Sun, Jui-Hung, Tsai, Jir-Shiong, Huang, Yu-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660278/
https://www.ncbi.nlm.nih.gov/pubmed/26607841
http://dx.doi.org/10.1038/srep16968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660278/
https://www.ncbi.nlm.nih.gov/pubmed/26607841
http://dx.doi.org/10.1038/srep16968

Ejemplares similares